Pfiz­er and BioN­Tech look to toss Mod­er­na patent suit, call­ing claims 'unen­force­able'

Pfiz­er and BioN­Tech took a swing at Mod­er­na’s Covid-19 patent claims in Mass­a­chu­setts fed­er­al court on Mon­day, call­ing them “in­valid,” “over­broad” and “un­en­force­able.”

The de­fen­dants al­so filed coun­ter­claims against the Cam­bridge, MA-based biotech, seek­ing a dis­missal of the case, re­cov­ery of court fees and an of­fi­cial judg­ment in­val­i­dat­ing Mod­er­na’s claims.

Mod­er­na sued Pfiz­er and BioN­Tech back in Au­gust, al­leg­ing that the part­ners’ Covid-19 vac­cine Comir­naty copied parts of Mod­er­na’s vac­cine tech­nol­o­gy patent­ed be­fore the pan­dem­ic, when it was de­vel­op­ing an mR­NA vac­cine for MERS, an­oth­er res­pi­ra­to­ry ill­ness.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.